Apo CII is a lipoprotein lipase (LPL) cofactor, the enzyme that hydrolyzes triglycerides, and apo-CII deficiency stimulates hypertriglyceridemia, an independent atherosclerosis risk factor. The gene discussed is AOPEP; the disease is atherosclerosis.